Lip cancer treatment with high dose rate brachytherapy.
We present 39 patients with lip carcinoma treated with HDR, (needles) with 5-5.5 Gy per 8-10 fractions b.i.d. (total dose 40.5-45 Gy). Three-year cause-specific survival and local control are 91 and 88% (95% T1-2, 74% T4, p<0.05). Acute and chronic reactions are like LDR cases. We think that HDR results are equivalent to LDR.
Guinot
José-Luis
JL
Department of Radiotherapy, Fundación Instituto Valenciano de Oncología (IVO), C/Profesor Beltrán Báguena 9, Valencia 46006, Spain.
Arribas
Leoncio
L
Chust
María Luisa
ML
Mengual
José Luis
JL
García Miragall
Enrique
E
Carrascosa
María
M
Escolar
Pedro Pablo
PP
Crispín
Vicente
V
Guardino
Carmen
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy*; D006801:Humans; D008048:Lip Neoplasms / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011832:Radiation Injuries; D011879:Radiotherapy Dosage